963 / 1631
NFT
DS 1-3
stratfiy:
residual mass > 2.5 cm
DS 1-2 v 3
BULK-ISRT
30 Gy
DLBCL
>16 years
Bulk
(
≥
7.5cm
any dimension
)
Outline of trial design in DLBCL
DS 4,5
Local practice
(RT recommended for
localised disease)
Central PET review
RT QA
PET
RCHOPx6
PET/CT
UK Phase 3 study in preparat on
Co-CI: T Illidge, G Mikhaeel